Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFE2L2 | Q16236 | 5/20 | 0.46 |
| ▸ | ACHE | P22303 | 2/20 | 0.42 |
| ▸ | KIF11 | P52732 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | CES2 | O00748 | 1/20 | 0.33 |
| ▸ | CES1 | P23141 | 1/20 | 0.33 |
| ▸ | DHODH | Q02127 | 1/20 | 0.33 |
| ▸ | CA3 | P07451 | 1/20 | 0.32 |
| ▸ | CA6 | P23280 | 1/20 | 0.32 |
| ▸ | CA5A | P35218 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.32 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19921795 | 0.87 | ALDH1A1 (0.46) | NFE2L2ALDH1A1CES2CES1CA3 | |
| SCHEMBL29716617 | 0.87 | ALDH1A1 (0.46) | NFE2L2ALDH1A1CES2CES1CA3 | |
| SCHEMBL13674310 | 0.76 | NFE2L2 (0.50) | NFE2L2ACHEKIF11ALDH1A1MEN1 | |
| SCHEMBL22109503 | 0.76 | NFE2L2 (0.38) | NFE2L2ACHEALDH1A1THRBCYP1A2 | |
| SCHEMBL6793057 | 0.73 | ALDH1A1 (0.42) | NFE2L2ACHEALDH1A1MEN1KMT2A | |
| SCHEMBL27465879 | 0.71 | DAO (0.47) | NFE2L2ACHE | |
| SCHEMBL25060878 | 0.71 | CA3 (0.42) | NFE2L2ALDH1A1MEN1KMT2ATHRB | |
| SCHEMBL8019931 | 0.69 | ALDH1A1 (0.42) | NFE2L2ALDH1A1MEN1KMT2AGAA | |
| SCHEMBL29350948 | 0.69 | ALDH1A1 (0.42) | NFE2L2ALDH1A1MEN1KMT2AGAA | |
| SCHEMBL19968270 | 0.69 | ALDH1A1 (0.42) | NFE2L2ALDH1A1CES2CES1CA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180065997-A1 | ELECTROLYTE FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY INCLUDING THE ELECTROLYTE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2018-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180065997-A1 | ELECTROLYTE FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY INCLUDING THE ELECTROLYTE | RER1, KCNN2, CLCN2 | NFE2L2 3362/4885ACHE 1783/4885KIF11 483/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.